Apyx Medical Inc (APYX) - Total Liabilities
Based on the latest financial reports, Apyx Medical Inc (APYX) has total liabilities worth $49.98 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Apyx Medical Inc's assets to evaluate the company's liquid asset resilience ratio.
Apyx Medical Inc - Total Liabilities Trend (1995–2025)
This chart illustrates how Apyx Medical Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Apyx Medical Inc total assets.
Apyx Medical Inc Competitors by Total Liabilities
The table below lists competitors of Apyx Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
UBM Development AG
VI:UBS
|
Austria | €740.65 Million |
|
Aemetis Inc
NASDAQ:AMTX
|
USA | $611.29 Million |
|
Humacyte Inc
NASDAQ:HUMA
|
USA | $113.26 Million |
|
FACT II Acquisition Corp. Class A Ordinary Shares
NASDAQ:FACT
|
USA | $9.52 Million |
|
Neumora Therapeutics, Inc.
NASDAQ:NMRA
|
USA | $45.67 Million |
|
Powercell Sweden
ST:PCELL
|
Sweden | Skr266.19 Million |
|
Hanla IMS Co. Ltd
KQ:092460
|
Korea | ₩105.90 Billion |
Liability Composition Analysis (1995–2025)
This chart breaks down Apyx Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Apyx Medical Inc (APYX) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.82 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Apyx Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Apyx Medical Inc (1995–2025)
The table below shows the annual total liabilities of Apyx Medical Inc from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $52.01 Million | +2.97% |
| 2024-12-31 | $50.51 Million | -3.46% |
| 2023-12-31 | $52.32 Million | +274.18% |
| 2022-12-31 | $13.98 Million | -4.96% |
| 2021-12-31 | $14.71 Million | +43.50% |
| 2020-12-31 | $10.25 Million | -23.59% |
| 2019-12-31 | $13.42 Million | +71.09% |
| 2018-12-31 | $7.84 Million | -12.44% |
| 2017-12-31 | $8.96 Million | +0.78% |
| 2016-12-31 | $8.89 Million | +10.48% |
| 2015-12-31 | $8.04 Million | -60.06% |
| 2014-12-31 | $20.14 Million | +70.01% |
| 2013-12-31 | $11.85 Million | +124.02% |
| 2012-12-31 | $5.29 Million | -13.64% |
| 2011-12-31 | $6.12 Million | +1.69% |
| 2010-12-31 | $6.02 Million | -6.38% |
| 2009-12-31 | $6.43 Million | -8.01% |
| 2008-12-31 | $6.99 Million | +244.55% |
| 2007-12-31 | $2.03 Million | -19.01% |
| 2006-12-31 | $2.51 Million | +36.97% |
| 2005-12-31 | $1.83 Million | +3.78% |
| 2004-12-31 | $1.76 Million | -1.22% |
| 2003-12-31 | $1.78 Million | -11.22% |
| 2002-12-31 | $2.01 Million | +27.33% |
| 2001-12-31 | $1.58 Million | +3.84% |
| 2000-12-31 | $1.52 Million | +14.28% |
| 1999-12-31 | $1.33 Million | -3.03% |
| 1998-12-31 | $1.37 Million | -14.97% |
| 1997-12-31 | $1.61 Million | -14.14% |
| 1996-12-31 | $1.88 Million | -41.08% |
| 1995-12-31 | $3.19 Million | -- |
About Apyx Medical Inc
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and … Read more